Sökresultat - "Dyer MJS"

Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study

Osterborg, A, Jewell, RC, Padmanabhan-Iyer, S, Kipps, TJ, Mayer, J, Stilgenbauer, S, Williams, CD, Hellmann, A, Furman, RR, Robak, T, Hillman, P, Trneny, M, Dyer, MJS, Piotrowska, M, Kozak, T, Gupta, IV, Phillips, JL, Goldstein, N, Struemper, H, Losic, N, Lisby, S, Wierda, WG

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk

Sava, GP, Speedy, HE, Di Bernardo, MC, Dyer, MJS, Holroyd, A, Sunter, NJ, Marr, H, Mansouri, L, Deaglios, S, Karabon, L, Frydecka, I, Jamroziak, K, Woszczyk, D, Juliusson, G, Smedby, KE, Jayne, S, Majid, A, Wang, Y, Dearden, C, Hall, AG, Mainou-Fowler, T, Jackson, GH, Summerfield, G, Harris, RJ, Pettitt, AR, Allsup, DJ, Bailey, JR, Pratt, G, Pepper, C, Fegan, C, Rosenquist, R, Catovsky, D, Allan, JM, Houlston, RS

Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia

Wierda, WG, Kipps, TJ, Mayer, J, Stilgenbauer, S, Williams, CD, Hellmann, A, Robak, T, Furman, RR, Hillmen, P, Trneny, M, Dyer, MJS, Padmanabhan, S, Piotrowska, M, Kozak, T, Chan, G, Davis, R, Losic, N, Wilms, J, Russell, CA, Osterborg, A

Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology

Went, M, Sud, A, Speedy, H, Sunter, NJ, Forsti, A, Law, PJ, Johnson, DC, Mirabella, F, Holroyd, A, Li, N, Orlando, G, Weinhold, N, van Duin, M, Chen, BW, Mitchell, JS, Mansouri, L, Juliusson, G, Smedby, KE, Jayne, S, Majid, A, Dearden, C, Allsup, DJ, Bailey, JR, Pratt, G, Pepper, C, Fegan, C, Rosenquist, R, Kuiper, R, Stephens, OW, Bertsch, U, Broderick, P, Einsele, H, Gregory, WM, Hillengass, J, Hoffmann, P, Jackson, GH, Jockel, KH, Nickel, J, Nothen, MM, da Silva, MI, Thomsen, H, Walker, BA, Broyl, A, Davies, FE, Hansson, M, Goldschmidt, H, Dyer, MJS, Kaiser, M, Sonneveld, P, Morgan, GJ, Hemminki, K, Nilsson, B, Catovsky, D, Allan, JM, Houlston, RS

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

Law, PJ, Berndt, SI, Speedy, HE, Camp, NJ, Sava, GP, Skibola, CF, Holroyd, A, Joseph, V, Sunter, NJ, Nieters, A, Bea, S, Monnereau, A, Martin-Garcia, D, Goldin, LR, Clot, G, Teras, LR, Quintela, I, Birmann, BM, Jayne, S, Cozen, W, Majid, A, Smedby, KE, Lan, Q, Dearden, C, Brooks-Wilson, AR, Hall, AG, Purdue, MP, Mainou-Fowler, T, Vajdic, CM, Jackson, GH, Cocco, P, Marr, H, Zhang, YW, Zheng, TZ, Giles, GG, Lawrence, C, Call, TG, Liebow, M, Melbye, M, Glimelius, B, Mansouri, L, Glenn, M, Curtin, K, Diver, WR, Link, BK, Conde, L, Bracci, PM, Holly, EA, Jackson, RD, Tinker, LF, Benavente, Y, Boffetta, P, Brennan, P, Maynadie, M, McKay, J, Albanes, D, Weinstein, S, Wang, ZM, Caporaso, NE, Morton, LM, Severson, RK, Riboli, E, Vineis, P, Vermeulen, RCH, Southey, MC, Milne, RL, Clavel, J, Topka, S, Spinelli, JJ, Kraft, P, Ennas, MG, Summerfield, G, Ferri, GM, Harris, RJ, Miligi, L, Pettitt, AR, North, KE, Allsup, DJ, Fraumeni, JF, Bailey, JR, Offit, K, Pratt, G, Hjalgrim, H, Pepper, C, Chanock, SJ, Fegan, C, Rosenquist, R, de Sanjose, S, Carracedo, A, Dyer, MJS, Catovsky, D, Campo, E, Cerhan, JR, Allan, JM, Rothman, N, Houlston, R, Slager, SL

Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients

Osterborg, A, Wierda, WG, Mayer, J, Hess, G, Hillmen, P, Schetelig, J, Schuh, A, Smolej, L, Beck, C, Dreyfus, B, Hellman, A, Kozlowski, P, Pfreundschuh, M, Rizzi, R, Spacek, M, Phillips, JL, Gupta, IV, Williams, V, Jewell, RC, Nebot, N, Lisby, S, Dyer, MJS

Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk

Crowther-Swanepoel, D, Broderick, P, Di Bernardo, MC, Dobbins, SE, Torres, M, Mansouri, M, Ruiz-Ponte, C, Enjuanes, A, Rosenquist, R, Carracedo, A, Jurlander, J, Campo, E, Juliusson, G, Montserrat, E, Smedby, KE, Dyer, MJS, Matutes, E, Dearden, C, Sunter, NJ, Hall, AG, Mainou-Fowler, T, Jackson, GH, Summerfield, G, Harris, RJ, Pettitt, AR, Allsup, DJ, Bailey, JR, Pratt, G, Pepper, C, Fegan, C, Parker, A, Oscier, D, Allan, JM, Catovsky, D, Houlston, RS

Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia

Osterborg, A, Foa, R, Bezares, RF, Dearden, C, Dyer, MJS, Geisler, C, Lin, TS, Montillo, M, van Oers, MHJ, Wendtner, CM, Rai, KR

Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia

Keating, M, Coutre, S, Rai, K, Osterborg, A, Faderl, S, Kennedy, B, Kipps, T, Bodey, G, Byrd, JC, Rosen, S, Dearden, C, Dyer, MJS, Hillmen, P

ATM is usually rearranged in T-cell prolymphocytic leukaemia

Yuille, MAR, Coignet, LJA, Abraham, SM, Yaqub, F, Luo, L, Matutes, E, Brito-Babapulle, V, Vorechovsky, I, Dyer, MJS, Catovsky, D

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

Osterborg, A, Dyer, MJS, Bunjes, D, Pangalis, GA, Bastion, Y, Catovsky, D, Mellstedt, H, Rankin, E, Tsekouras, C, Cavalli, F, Sessa, C, Huhn, D, Marcus, R, Maughan, T, Poynton, C, Nissen, N, Carney, D, Brittinger, G, Uppenkamp, M, Elonen, E, Teerenhovi, L, ngert, Willemze, R, KluinNelemans, J, Thomas, J, Epenetos, AA, Nethersell, A, Dyer, M, Dicato, M, Coiffier, B, Ranada, JMF, Crowther, D, Woll, P, Raemakaers, J, dePauw, B, Degos, L, issellbrecht, Reiffers, J, Fassas, A, Anagnostopoulos, A, Jaeger, U, Stahel, RA

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

Catovsky, D, Richards, S, Matutes, E, Oscier, D, Dyer, MJS, Bezares, RF, Pettitt, AR, Hamblin, T, Milligan, DW, Child, JA, Hamilton, MS, Dearden, CE, Smith, AG, Bosanquet, AG, Davis, Z, Brito-Babapulle, V, Else, M, Wade, R, Hillmen, P

The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia

Dyer, MJS^{Aff1, ID2402528_cor1}, Oscier, DG

Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization

Sanchez-Izquierdo, D, Siebert, R, Harder, L, Marugan, I, Gozzetti, A, Price, HP, Gesk, S, Hernandez-Rivas, JM, Benet, I, Solé, F, Sonoki, T, Le Beau, MM, Schlegelberger, B, Dyer, MJS, Garcia-Conde, J, Martinez-Climent, JA^{Aff1, ID2402207_cor16}

Establishment of the B cell precursor acute lymphoblastic leukemia cell line MUTZ-5 carrying a (12;13) translocation

Meyer, C, MacLeod, RAF, Quentmeier, H, Janssen, JWG, Coignet, LJ, Dyer, MJS, Drexler, HG^{Aff1, ID2402212_cor7}

B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene

Lens, D, Coignet, LJA, Brito-Babapulle, V, Lima, CSP, Matutes, E, Dyer, MJS, Catovsky, D

Potential role for concurrent abnormalities of the cyclin D1, p16^CDKN2 and p15^CDKN2B genes in certain B cell non-Hodgkin’s lymphomas. Functional studies in a cell line (Granta 519)

Jadayel, DM, Lukas, J, Nacheva, E, Bartkova, J, Stranks, G, De Schouwer, PJJC, Lens, D, Bartek, J, Dyer, MJS, Kruger, AR, Catovsky, D

Humanized CD52 monoclonal antibody Campath-1H as first-line treatment in chronic lymphocytic leukaemia

Osterborg, A, Fassas, AS, Anagnostopoulos, A, Dyer, MJS, Catovsky, D, Mellstedt, H

Lack of somatic hypermutation of IG VH genes in lymphoid malignancies with t(2;14)(p13;q32) translocation involving the BCL11A gene

Küppers, R^{Aff1, ID2402480_cor1}, Sonoki, T, Satterwhite, E, Gesk, S, Harder, L, Oscier, DG, Tucker, PW, Dyer, MJS, Siebert, R

A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia

Speedy, HE, Di, Bernardo MC, Sava, GP, Dyer, MJS, Holroyd, A, Wang, Y, Sunter, NJ, Mansouri, L, Juliusson, G, Smedby, KE